We review here the state of the art of diagnosis and treatment of AML and provide insights into the emerging novel biomarkers and therapeutic agents that are anticipated to be useful for the implementation of personalized medicine in AML.
Samer Khaled, MD
Advertisement
Articles by Samer Khaled, MD
Advertisement
Latest Updated Articles
Acute Myeloid Leukemia: Biologic, Prognostic, and Therapeutic InsightsPublished: April 16th 2016 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
2
Tucatinib Regimen Improves PFS in HER2+ Metastatic Breast Cancer
3
Ficerafusp Alfa/Pembrolizumab Receives FDA BTD in Front-Line HNSCC
4
Safety Strategies for GPRC5D-Directed and T-Cell Engager Therapies
5
